Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (91-100 of 493) with videos related to

Pageof 50
Sort By:
Cureus|June 12, 2026
Attention-Deficit/Hyperactivity Disorder, Racial Disparities, and Involvement in the Juvenile Justice System: A Narrative ReviewJustin B Atkins, Oscar A Toro Ruilowa, Deanna Chea, et al.
Cureus|May 25, 2026
Utilization and Operational Performance of the 988 Suicide & Crisis Lifeline in Nevada: A Retrospective Descriptive AnalysisOscar A Toro Ruilowa, Deanna Chea, Justin B Atkins, et al.
Transfusion|July 1, 1989
Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedureT Ryan, M B Atkins, J W Mier, et al.
ACG Case Reports Journal|March 9, 2018
Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced EnteritisPietro Diana, Charoen Mankongpaisarnrung, Michael B Atkins, et al.
Urology|December 18, 2001
Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgeryJ A Gollob, M P Upton, W C DeWolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Toxicities of Immunotherapy for the PractitionerJeffrey S Weber, James C Yang, Michael B Atkins, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1995
Rapidly progressive glomerulonephritis after immunotherapy for cancerM G Parker, M B Atkins, A A Ucci, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1990
Augmentation of insulin autoantibodies following interleukin-2 and lymphokine activated killer cell therapyR W Bergstrom, M B Atkins, J W Mier, et al.
Oncogene|November 2, 1995
The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110J M Mazzarelli, G B Atkins, J V Geisberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2016
Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac InjuryBenita Sjögren, Sergio Parra, Kevin B Atkins, et al.
Pageof 50

Showing results (91-100 of 493) with videos related to

Sort By:
Pageof 50
Cureus|June 12, 2026
Attention-Deficit/Hyperactivity Disorder, Racial Disparities, and Involvement in the Juvenile Justice System: A Narrative ReviewJustin B Atkins, Oscar A Toro Ruilowa, Deanna Chea, et al.
Cureus|May 25, 2026
Utilization and Operational Performance of the 988 Suicide & Crisis Lifeline in Nevada: A Retrospective Descriptive AnalysisOscar A Toro Ruilowa, Deanna Chea, Justin B Atkins, et al.
Transfusion|July 1, 1989
Lymphokine-activated killer cell generation and recovery. Comparison of an automated cell processing device and a manual procedureT Ryan, M B Atkins, J W Mier, et al.
ACG Case Reports Journal|March 9, 2018
Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced EnteritisPietro Diana, Charoen Mankongpaisarnrung, Michael B Atkins, et al.
Urology|December 18, 2001
Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgeryJ A Gollob, M P Upton, W C DeWolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Toxicities of Immunotherapy for the PractitionerJeffrey S Weber, James C Yang, Michael B Atkins, et al.
Journal of the American Society of Nephrology : JASN|April 1, 1995
Rapidly progressive glomerulonephritis after immunotherapy for cancerM G Parker, M B Atkins, A A Ucci, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1990
Augmentation of insulin autoantibodies following interleukin-2 and lymphokine activated killer cell therapyR W Bergstrom, M B Atkins, J W Mier, et al.
Oncogene|November 2, 1995
The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110J M Mazzarelli, G B Atkins, J V Geisberg, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 5, 2016
Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac InjuryBenita Sjögren, Sergio Parra, Kevin B Atkins, et al.
Pageof 50